South East London Area Prescribing Committee (APC) 26 January 2016 at Tooley Street. Approved minutes
|
|
- Magnus Turner
- 5 years ago
- Views:
Transcription
1 South East London Area Prescribing Committee (APC) 26 January 2016 at Tooley Street 1. Welcome, and Introductions Approved minutes 2. Conflicts of Interest declarations The Chair requested any interests relating to the meeting agenda be declared. There were no declarations noted. Members were reminded of the need to submit up to date declarations of interest. 3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the October meeting were accepted as accurate. 4. Matters Arising IBD monitoring framework has been embedded in the contract monitoring arrangements for NHS Lambeth, NHS Southwark and NHS Bromley with King s College Hospital (KCH) and Guy s and St Thomas s (GSTfT). 5. Pathway updates Ophthalmology More time for consultation and further investigation into costs and local commissioning variations is required. The Commissioning Support Unit representative is to meet with Medicines Management CCG leads and the outcome will be fed back via the Ophthalmology group. Psoriasis The dermatology specialists are due to meet in the next two weeks and this will be followed up by a meeting of the full pathway development group in March The committee was asked to note that the existing Lambeth guidance has been well received by the group. 6. NICE guideline on Medicines Optimisation and baseline assessment The baseline assessments for each organisation across SEL have been collated and rag rated. The main outcome is to confirm there is a good system of reporting errors/safety issues in secondary care organisations. However there is no one good mechanism for reporting in primary care. The committee discussed the National Reporting and Learning system (NRLS) but felt this was not fully utilised by general practice. Various options to improve the situation were discussed including: Sharing of the monthly GSTfT Medicines Information newsletter with primary care Attendance at acute trust Medicines Safety Forums (already in place in some CCGs) Reporting safety issues via the yellow card system Nhs.net accounts for community pharmacies The committee discussed various local processes and schemes which have raised awareness of safety issues but agreed this is a concern in primary care due to the voluntary nature of reporting and variation in reporting systems..
2 ACTION: Chair to raise lack of potential improvements in reporting processes in primary care with Care Quality Commission (CQC) Inspector of General Practice 7. South East London Interface Policy and NHS and Private Interface Prescribing Guide i. Interface Policy The policy has been updated in line with comments received and the committee approved the revision. ii. NHS and Private Interface Prescribing Guide The following amendments were agreed: Page 1 section 2 add for the same condition Appendix 2 amend wording to You will always be required to pay for the first private prescription from your consultant while your GP considers if continuing the prescriptions on the NHS would be appropriate. The committee noted that the letter to the consultant should also be seen by the patient and that guidance on prescribing outside of the formulary should be strengthened, both in the letter and section 3.7. ACTION: Author to revise in line with discussion and policies to be sent for Chair s action to ratification. 8. SEL APC Terms of Reference The terms of reference are due for annual review and have been discussed at the January NDP meeting. The committee was asked to focus on the declaration of interests (DOI) process in particular, considering the following questions: How often should the DoI form be completed and how should DoIs be updated through the year? Annually in line with the financial year. How far back should the DoI go? Currently the previous 12 months is requested is this sufficient? How far back should the Register of Interests cover? 2 years maximum How detailed should the DoI record be? For example: Dates of the meetings attended Should the actual payment made for each also be declared? The committee felt the level of detail on the current form is enough. Where members declare an interest it should be at the Chair s discretion as to whether further detail is necessary. How should DoI for new members joining part way through the year be recorded? New members will be required to complete a declaration on joining and will then join the rolling programme. How should DoI for those in attendance at the meetings be recorded? Submitted DOIs should be summarised by the Business Support Officer and the summary presented at each meeting. Attendees to sign the summary to confirm that the details held are correct and update as necessary. How should DoI for pathways/sub-groups be recorded? The DOI process for pathway groups should align with the APC/NDP process.
3 What process should be used for members/participants failing to complete their DoI by specified deadlines? If members fail to respond by the initial deadline they should receive 2 reminders one week apart, followed by a letter from the Chair. Failure to respond at this stage will result in a sanction banning the individual from attending committee meetings. Hard copies will also be provided at meetings and the Chair updated on failure to submit. In the case of applicants for drug submissions it was agreed that the formulary submission form will be revised to include the DOI and submissions will not be heard unless this has been fully completed by the applicant(s). What should the process be if a member makes a declaration in a meeting? Should they remain part of the discussions? Can they remain in the meeting room and hear the discussions but not contribute to them? Should they leave the room whilst the decision is made? It will be the responsibility of the Chair to decide the appropriate process on a case by case basis. Should the register of DoIs be noted at regular intervals at NDP meetings (eg quarterly)? This is covered by the summary to be presented at each meeting Should all DoI forms be signed or is acceptable? DOIs sent from the individual s nhs.net mail account will be accepted as signed. Any further comments on the TOR should be directed to the APC Support Pharmacist. ACTION: APC Support Pharmacist to update the TOR in line with discussions. 9. Horizon scanning new drugs and indications for 16/17 The GSTfT Medicines Information representative presented a summary of horizon scanning of CCG commissioned drugs for 2016/17. The key points were: IBD drugs increased use of biosimilars and more patients treated in optimally in primary care Lipid modification drugs carry a high financial risk for 2016/17due to the NICE guideline issued in July Heart failure carries a moderate to high financial risk Licensed medicinal e-cigarettes carry a high financial risk, with the potential to increase prescribing costs by 1.1m per 100,000 population per year, if a health economy accepts that these are prescribable. House dust mite allergen immunotherapy is anticipated to be licensed in the uk in Anticipated costs would be 200,000 per 100,000 population and it is expected to be tariff included. IF pregabalin generic become available with the full set of licensed indications, and this leads to a 70% decrease in the Drug Tariff cost for generic this would decrease prescribing costs by 317,000 per 100,000 population assuming that the NHS in England currently spends about 240m on this medicine. Diabetes drugs carry a high financial risk following the release of new NICE guidance. The availability of biosimilar insulin glargine may mitigate this anticipated increase to an extent. SEL guidance on diabetes will be developed in 2016/17. Insulin pump use
4 has the potential to increase and is tariff excluded meaning local funding decisions will need to be made. Macular oedema has a high financial risk with treatment with both aflibercept and dexamethasone implants for DMO having a significant cost impact. The SEL Ophthalmology pathway is in development and it is recommended that a local formulary is agreed for ophthalmology specials. 10. Are there any quality focused areas that the APC can work on collaboratively in 16/17? It was suggested the SEL APC focus on an antibiotic stewardship campaign for distribution in autumn The focus of the campaign would be on targeting the message appropriately, using existing materials and covering all parts of the system. The Communications team would cost out and map the campaign. It was suggested a task and finish group be set up, led by a microbiologist. It was suggested the director of the Hurley Group and A&E consultants be invited to participate. The Lewisham GP representative volunteered to lead on setting up the group. The GSTfT clinical representative will talk to the relevant colleagues re microbiologist representation on the group. ACTION: Task and Finish Group to be set up Lewisham CCG to lead 11. Antipsychotics in patients with learning disabilities (LD) SLAM and Oxleas representatives delivered a presentation on the use of antipsychotics in patients with learning disabilities. The key points were: Oxleas Prevalence (in Oxleas) of antipsychotic prescribing for people with LD is low Indications for such treatment are clearly documented in the majority of cases, and most patients are reviewed annually Few prescriptions (in Oxleas) are for the management of aggressive behaviour which suggests that other strategies are put in place and are effective. Monitoring of EPS and metabolic parameters is good (in relative terms) but still some way short of the audit standard (absolute terms) Findings discussed by LD services with a focus on regular assessment of side effects There are practical barriers associated with phlebotomy in the Greenwich LD team and interface issues with the pathology system in both Bexley and Greenwich. Action plans focus on these areas. SLAM Around half patients in sample were prescribed an antipsychotic Indication for prescription was noted for all patients Testing for extrapyramidal side effects (EPS) and metabolic testing were not evident for all patients Plasma glucose and lipid testing was more evident in SLAM than nationally. We suspect that assessments (BP, weight) documented on paper MEWS charts are not recorded in epjs. MEWS not checked for audit Results have been discussed with the LD clinical governance group and leads. A quality improvement plan (QIP) is in place to improve practice across trust LD services. Started November 2015
5 Pharmacy has completed a QIP aimed at improving EPS monitoring. Completed December 2015 Electronic MEWS currently being discussed in trust CQC reported SLAM LD services to be outstanding 12. Items for information/ratification i. New/revised formulary recommendations and position statements a. New recommendations b. Revised recommendations 10 and 24 c. Position statement 002 ii. Shared care guideline: Disease Modifying Anti-rheumatic Drugs (DMARDs): Azathioprine, Hydroxychloroquine, Leflunomide, Methotrexate, Mycophenolate and Sulfasalazine for the treatment of autoimmune rheumatic diseases in Adults VB declared attendance at RA advisory boards (see submitted declaration for details) iii. Shared care guideline: Nebulised mucolytic and antibiotic solutions for the treatment of Cystic Fibrosis in existing patients only iv. Over Active Bladder (OAB) Care Pathway for adults in primary care v. Treatment pathway for chronic constipation in adults vi. Pharmacological Management of Neuropathic Pain in Adults Review date to be amended to 6 months (May 2016) vii. Rheumatoid Arthritis Biologic Drug Treatment Pathway The committee noted that section numbers on page 8 of the pathway have been amended to align with the revision. The pathway was ratified. viii. ix. Seronegative Spondyloarthropathy Biologic Drug Treatment Pathway South East London Responsible Respiratory Prescribing Group (SEL RRP) Terms of Reference x. New Drugs Panel minutes Sept-Nov 2015 xi. NICE Technology Appraisal Guidance Summary xii. Correspondence to Bromley CCG/Bromley Healthcare/Greenwich CCG re administration of depot injections by nurses xiii. Correspondence to SLAM/KCH/Lambeth Council re treatment pathway for drugs used in alcohol dependence All items were noted/ratified as required. 13. AOB BNF errors: the committee was asked to note there are a number of dosing errors in the paper version of BNF70. A cover sheet is to be issued detailing the errors. In the interim members were advised to consult the digital copy of the BNF which is correct. The BNF app is also correct. Public health has informed the Chair they will not be sending a representative to APC on a regular basis. They will attend only if invited for a specific item on the agenda or if an item is of interest to PH meetings: Thursday 24 March pm-4.00pm Room 407, 1 Lower Marsh Thursday 23 June pm-4.00pm Room 407, 1 Lower Marsh Thursday 13 October pm-4.00pm Room 407, 1 Lower Marsh
HARROGATE & RURAL DISTRICT AREA PRESCRIBING COMMITTEE (HaRD APC) Application for a new product to be added to the formulary
Guidance on completing the form Your submission should be comprehensive and indicate which, if any, information has been supplied by a pharmaceutical company. The application must be completed with the
More informationSouth East London Area Prescribing Committee. Annual Report. April March 2017
South East London Area Prescribing Committee Annual Report April 2016 - March 2017 Executive Summary This report summarises the activities of the South East London Area Prescribing Committee (SEL APC)
More informationRegional Medicines Optimisation Committee Briefing Best Value Biologicals: Adalimumab Update 2
Regional Medicines Optimisation Committee Briefing Best Value Biologicals: Adalimumab Update 2 Adalimumab RMOC Update 1: https://www.sps.nhs.uk/articles/rmoc-briefing-paper-on-adalimumab/ The purpose of
More informationMinutes. HMR CCG, Nye Bevan House, Rochdale
Minutes 9 th March 2017, 1pm-3pm HMR CCG, Nye Bevan House, Rochdale Present: Dr Marlon Morias (MM) GP Prescribing Lead, North Manchester CCG Dr Tom Leckie (TL) Consultant in Emergency Medicine, Pennine
More informationONLINE QUALITY IMPROVEMENT SYSTEM SPECIFICATION
ONLINE QUALITY IMPROVEMENT SYSTEM SPECIFICATION Page 1 of 21 Table of Contents 1. OVERVIEW OF LONDONADASS... 3 2. BACKGROUND TO REQUIREMENT... 4 3. KEY OBJECTIVES... 5 4. DATA SOURCES... 6 5. DATA FEEDS...
More informationManagement Board Terms of Reference
Management Board Terms of Reference 1. Constitution This Board is established by Board of Directors as the senior operational board of the Royal United Hospitals Bath NHS Foundation Trust. 2. Terms of
More informationNHS England Regional Medicines Optimisation Committee (North) Summary Notes and Actions
NHS England Regional Medicines Optimisation Committee (North) Summary Notes and Actions Wednesday 28 th February 2018, 1-4pm, Webinar. Chair: Dr Mike Prentice (Medical Director, NHSE North Region) Attendees:
More informationUKMI CONTRIBUTIONS TO THE MEDICATION SAFETY AGENDA. Ben Rehman Director, London Medicines Information Service
UKMI CONTRIBUTIONS TO THE MEDICATION SAFETY AGENDA Ben Rehman Director, London Medicines Information Service A broad portfolio Patient care Organisational and system safety Numerous Medicines Q&As Enquiry
More informationTechnology appraisal guidance Published: 28 September 2016 nice.org.uk/guidance/ta407
Secukinumab for active ankylosing spondylitis after treatment with non- steroidal anti-inflammatory drugs or TNF-alpha inhibitors Technology appraisal guidance Published: 28 September 16 nice.org.uk/guidance/ta407
More informationElectronic Prescribing and Medicines Administration Project Overview
Electronic Prescribing and Medicines Administration Project Overview 1. Project Background The purpose of the project is to implement an Electronic Prescribing and Medicines Administration (epma) system
More informationGREATER MANCHESTER HEALTH AND SOCIAL CARE STRATEGIC PARTNERSHIP BOARD EXECUTIVE. Establishing Leadership and Accountability in Shadow Form
5a GREATER MANCHESTER HEALTH AND SOCIAL CARE STRATEGIC PARTNERSHIP BOARD EXECUTIVE Date: 13 th November 2015 Subject: Report of: Establishing Leadership and Accountability in Shadow Form Liz Treacy PURPOSE
More informationCancer Vanguard. Biosimilars Trust Policy Template
Cancer Vanguard Biosimilars Trust Policy Template Aim of this document: The document provides generic guidance and outline for the development of local trust policies in relation to the adoption of biosimilars
More informationManaging Conflicts of Interests NHS Clinical Commissioning Groups
Managing Conflicts of Interests NHS Clinical Commissioning Groups Benchmarking of the 2017-18 mandated audit reviews Contents 1. Context 2. Overall Profile of Compliance 3. Analysis of the 5 Areas The
More informationBhavana Reddy (BR) Head of Prescribing Support RDTC Andrew White (AW) Head of Medicines Optimisation GM Shared Service
GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Date: Thursday 21 st July 2016 Time: 1pm 3pm Venue: Boardroom, New Century House, Tameside and Glossop. Present: Name Designation Organisation CCG members
More informationCENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST. Board of Directors Monday 14 th November Workforce Performance Mid-Year Report
CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Board of Directors Monday 14 th November 2016 Workforce Performance Mid-Year Report Purpose of Report To provide the Board of Directors with
More informationMinutes of the Somerset Prescribing Forum held in Meeting Room 1, Wynford House, Lufton Way, Yeovil, Somerset on Wednesday 15 January 2014
Minutes of the Somerset Prescribing Forum held in Meeting Room 1, Wynford House, Lufton Way, Yeovil, Somerset on Wednesday 15 January 2014 Present: Chair, Drug & Therapeutics Committee, Taunton & Somerset
More informationNHS SHEFFIELD CLINICAL COMMISSIONING GROUP CONSTITUTION
NHS SHEFFIELD CLINICAL COMMISSIONING GROUP CONSTITUTION Version: 5.2 NHS Commissioning Board Effective Date: October 2016 1 1 CONTENTS Part Description Page Foreword 3 1 Introduction and Commencement 4
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate. Indicator Process Guide. Published December 2017
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Indicator Process Guide Published December 2017 Please note that this is an interim factual update to the NICE Indicator
More informationAssistant Director of Quality Improvement and Clinical Assurance
: Primary Care Commissioning Committee Meeting Part 1 Date Wednesday 19 th April 2017 Time 10:30 12.00pm Venue Rooms 5.3, 15 Marylebone Road, London, NW1 5JD Present Membership Dominique Kleyn DK Governing
More informationANGUS COMMUNITY HEALTH PARTNERSHIP
ANGUS COMMUNITY HEALTH PARTNERSHIP of the Meeting of Angus Community Heath Partnership Committee held on Monday, 26 April 2010 at 13:30, Lintrathen Room, Whitehills Health & Community Care Centre, Forfar
More informationSTRATEGIC WORKFORCE FRAMEWORK
MEETING DATE: 8 November 2012 AGENDA ITEM NUMBER: Item 7.2 AUTHOR: JOB TITLE: DEPARTMENT: Rachel Craven Commissioning Specialist North Yorkshire and Humber Commissioning Support Unit REPORT TO THE CLINICAL
More informationCPPE Leading for change Programme handbook
Introduction Welcome to the CPPE Leading for change leadership and management for hospital pharmacy professionals programme. This fully-funded programme is open to mid to senior grade hospital pharmacists
More informationLeeds Health Commissioning and System Integration Board. Terms of Reference
APPENDIX A Leeds Health Commissioning and System Integration Board Terms of Reference Version: 15.0 DRAFT Approved by: Date approved: Date issued: Responsible Director: Review date: [+6 months from approval]
More informationMinutes from the Health and Well-Being Board Financial Planning Group Thursday 7 th August 2014 Edgware Hospital 4pm 5.30pm
Minutes from the Health and Well-Being Board Financial Planning Group Thursday 7 th August 2014 Edgware Hospital 4pm 5.30pm Present: (KK) Kate Kennally, Strategic Director for Communities, London Borough
More informationSPS and support to RMOCs
SPS and support to RMOCs What is SPS? The Specialist Pharmacy Service 1974 - an important year First major reconfiguration of the NHS Specialist Pharmacy Service was borne! The review of Specialist Pharmacy
More informationBGMA Associate Membership
BGMA Associate Membership Making medicines affordable Promoting Innovation November 2011 GENERICS -THE FACTS Generic medicines meet the same standards of quality, safety and efficacy as originator brands.
More informationMembership Development Strategy
Membership Development Strategy 204-207 May 204 Contents Page Introduction 3. Membership Development. Our Aim 4.2. Ensuring Diversity 4-5.3 Membership Community 5.4 Membership Recruitment and Involvement
More informationBoard of Directors Audit Committee
Board of Directors Audit Committee Terms of Reference (version 4) (as adopted 22 February 2007 and amended 18 September 2014, 19 November 2015 and January 2017) Reference to the Committee shall mean the
More informationNational Quality Board (NQB) Workplan
National Quality Board (NQB) Workplan Background 1. Following agreement at the July 2015 meeting of the Five Year Forward View (5YFV) Board that the ALB CEO s should work with the DH to ensure that delivery
More informationCorporate Objective addressed by this paper (please select one or more with an X):
Enclosure: I genda item: 13 GOVERNING BODY Title of paper: QIPP Delivery Update 2018/19 Date of meeting: 9 th January 2019 Presented by: Robert Shaw Prepared by: Kat Macann Title: Director of Commissioning
More informationRISK MANAGEMENT STRATEGY
Agenda Item No: 15 RISK MANAGEMENT STRATEGY PURPOSE: The Risk Management Strategy has been updated to reflect the revised approach to the Corporate Risk Register and Board Assurance Framework and to reflect
More informationBusiness Case Process
Reference Number: GuCG005 Version: 1.0 Name of Originator / Author & Organisation: Responsible LECCG Committee: LECCG Executive Lead: Date Approved by LECCG Authorising Committee: Matthew Broughton & Ben
More informationCapital and Estates Forum 20 th January 2016, 14:00pm -16:00pm, Meeting Room The Broadway, Wimbledon, London, SW19 1RH
MINUTES Members in attendance Name Organisation Designation Hardev Virdee (Co-Chair) Wandsworth CCG SWL Chief Finance Officer Lead William Cunningham Davis NHS England Head of Primary Care, South London
More informationEDUCATION Careers Education, Information, Advice and Guidance Policy
EDUCATION Careers Education, Information, Advice and Guidance Policy Document title: Careers Education, Information, Advice and Guidance Policy Version number: 1.0 Policy Status Approved Date of Issue
More informationLeading for change - leadership and management for hospital pharmacy professionals
CENTRE FOR PHARMACY POSTGRADUATE EDUCATION Leading for change - leadership and management for hospital pharmacy professionals February 2018 Introduction Welcome to the CPPE Leading for change leadership
More informationGRIEVANCE AND DISPUTE POLICY
GRIEVANCE AND DISPUTE POLICY Last Review Date Adopted 2 nd April 2013 Approving Body Executive Committee Date of Approval 4 th October 2017 Date of Implementation 4 th October 2017 Next Review Date September
More informationGS1 and PEPPOL standards in Health Care - Demonstrator sites
GS1 and PEPPOL standards in Health Care - Demonstrator sites Prepared by Commercial Directorate Department of Health June 2015 Introduction As part of the adoption of the global GS1 and PEPPOL standards
More informationGREATER MANCHESTER HEALTH AND SOCIAL CARE DEVOLUTION STRATEGIC PARTNERSHIP BOARD. Establishing Leadership and Accountability in Shadow Form
6 GREATER MANCHESTER HEALTH AND SOCIAL CARE DEVOLUTION STRATEGIC PARTNERSHIP BOARD Date: 23 rd October 2015 Subject: Report of: Establishing Leadership and Accountability in Shadow Form Liz Treacy PURPOSE
More informationOur Healthier South East London (OHSEL) The SEL STP. Programme Director: Community Based Care
Our Healthier South East London (OHSEL) The SEL STP Programme Director: Community Based Care Job Title: Programme Director: Community Based Care Band: 9 Responsible to: Accountable to: Responsible for:
More informationJOB DESCRIPTION - CHIEF OPERATING OFFICER
JOB DESCRIPTION - CHIEF OPERATING OFFICER JOB TITLE: RESPONSIBLE TO: KEY RELATIONSHIPS: Chief Operating Officer Chief Executive Chief Executive and Chair Board members Executive Team Senior clinicians,
More informationWOMEN IN INTERNATIONAL AFFAIRS NETWORK
WOMEN IN INTERNATIONAL AFFAIRS NETWORK Application Pack HEAD OF PROGRAMMES Dear applicant, Thank you for your interest in the post of Head of Programmes with the Women in International Affairs Network.
More informationOur People. A People Strategy. for Workforce and Organisational Development
Our People A People Strategy for Workforce and Organisational Development to support Herefordshire and Worcestershire Sustainability and Transformation Plan 2017-21 In partnership with: 1 Contents Foreword
More informationApologies for absence were noted from Ms Claire Dobson, Dr Frances Elliot and Dr Seonaid McCallum. 2 MINUTES OF PREVIOUS MEETING ON 7 FEBRUARY 2018
CONFIRMED MINUTES OF THE MEETING OF THE FIFE DRUGS AND THERAPEUTICS COMMITTEE HELD AT 12.30PM ON WEDNESDAY 18 APRIL 2018 IN THE PENTLAND SUITE, WHYTEMAN S BRAE HOSPITAL, KIRKCALDY. Present: Mrs Evelyn
More informationKnowledge Management Strategy
Knowledge Management Strategy 2013-2017 Promoting the management & use of knowledge for the best patient care Margaret Rowley April 2013 WAHT-code Page 1 of 13 Version 1.3 DOCUMENT CONTROL Originator:
More informationDrug coding in Wales. Robin Burfield Health Solution Wales. 13th February 2002
Drug coding in Wales Robin Burfield Health Solution Wales 13th February 2002 How Wales in organised National Assembly for Wales Health Solutions Wales Prescribing Services Unit (PSU) Hospital Pharmacy
More informationGOVERNANCE SMART objectives / SUHFT board development programme
GOVERNANCE SMART objectives / SUHFT board development programme Specific objective Measurable Success Actions required Relevance / Outcome Owner Time Documented set of Trust Board objectives will be in
More informationExternal Audit: Annual Audit Letter
INFRASTRUCTURE, GOVERNMENT AND HEALTHCARE External Audit: Annual Audit Letter 2005-06 Southport and Ormskirk Hospital NHS Trust September 2006 AUDIT Content The contacts at KPMG in connection with this
More informationRDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Product (CTIMPs)
RDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: Document Summary: Document
More informationNHS Halton CCG Communications. and Marketing Strategy
NHS Halton CCG Communications and Marketing Strategy 2016-2019 1. Introduction It is well documented the NHS has recently been through a period of unprecedented change, and it will continue to face many
More informationGOVERNING BODY. Corporate Objective addressed by this paper (please select one or more with an X):
Enclosure: M Agenda item: 17 GOVERNING BODY Title of paper: QIPP Delivery Update 2018/19 Date of meeting: 4 th July 2018 Presented by: Robert Shaw Prepared by: Kat Macann Title: Director of Commissioning
More informationRoyal Devon & Exeter NHS Foundation Trust Governance Review
Royal Devon & Exeter NHS Foundation Trust Governance Review Em Wilkinson-Brice Director of Nursing & Patient Care Suzanne Tracey Director of Finance & Business Development Richard Schofield Corporate Affairs
More informationNHS Lambeth Clinical Commissioning Group Constitution
NHS Lambeth Clinical Commissioning Group Constitution Our mission is to improve the health and reduce health inequalities of Lambeth people and to commission the highest quality health services on their
More information2 Year Operating Plan Summary
2 Year Operating Plan 2017 2019 Summary December 2016 Introduction This document presents a summary of the Kingston Hospital NHS Foundation Trust s 2 year Operating Plan for 2017/19 which was submitted
More informationSTAFFORD & SURROUNDS DECOMMISSIONING & DISINVESTMENT OF SERVICES
Stafford & Surrounds Clinical Commissioning Group STAFFORD & SURROUNDS DECOMMISSIONING & DISINVESTMENT OF SERVICES Agreed at Governing Body 09 December 2013 Date:.. Signature:. Chair Stafford & Surrounds
More informationQuality Payments Scheme Updating NHS website profiles User guide
Quality Payments Scheme 2018-19 Updating NHS website profiles User guide Document Author: Richard Moore Created Date: 01/02/17 Current Issue Date: 19/11/18 Version Number: 4 Contents Introduction... 3
More informationSubmission to the Department of Health (Fed) regarding. Biosimilar Uptake Drivers Implementation. This joint submission is made by:
Submission to the Department of Health (Fed) regarding Biosimilar Uptake Drivers Implementation This joint submission is made by: The Society of Hospital Pharmacists of Australia (SHPA) SHPA is the national
More informationEnvironment and resource efficiency Strategy and action plan 2016/17
Environment and resource efficiency Strategy and action plan 2016/17 Date: 27 June 2016 Version number: v1 Owner: David Jukes Approval route: NHSBSA Leadership Team Approval status: Approved 1. Introduction
More informationPublic Engagement with Research
University of Oxford Public Engagement with Research Strategic Plan 1.0 Preamble The purpose of this Plan is two-fold: 1.1 to frame an ambitious vision for Public Engagement with Research at Oxford; 1.2
More informationEAST LANCASHIRE HEALTH ECONOMY MEDICINES MANAGEMENT BOARD IN SEMINAR ROOM 9, LEARNING & DEVELOPMENT CENTRE, ROYAL BLACKBURN HOSPITAL
EAST LANCASHIRE HEALTH ECONOMY MEDICINES MANAGEMENT BOARD MINUTES OF THE MEETING HELD ON WEDNESDAY 20 th APRIL 2016 AT 12.30pm IN SEMINAR ROOM 9, LEARNING & DEVELOPMENT CENTRE, ROYAL BLACKBURN HOSPITAL
More informationCheshire Pioneer IDCR Project. Benefits Realisation Manager
Project Benefits Realisation Manager Contents 1 Introduction... 3 1.1 Purpose of this document... 3 2 Project Overview... 3 1.1. Project Scope... 3 1.2. Project Aim... 4 1.1. Geography... 4 1.2. The Partner
More informationWorkforce Race Equality Standard 2017
Workforce Race Equality Standard July Introduction The purpose of this report is to provide the key findings for The Royal Marsden in relation to the Workforce Race Equality Standard (WRES) in. The Equality,
More informationItem Number: 8.3. Governing Body Meeting: 5 February Report Sponsor Amanda Bloor Chief Officer. Report Author Amanda Bloor Chief Officer
Item Number: 8.3 Governing Body Meeting: 5 February 2015 Report Sponsor Amanda Bloor Chief Officer Report Author Amanda Bloor Chief Officer 1. Title of Paper: Harrogate Public Sector Leadership Board 2.
More informationDECOMMISSIONING AND DISINVESTMENT STRATEGY CCG: CS01
NHS Milton Keynes Clinical Commissioning Group DECOMMISSIONING AND DISINVESTMENT STRATEGY CCG: CS01 Version: 0.1 Ratified by: To be ratified by Board Date ratified: 26.07.16 Name of originator / author:
More informationMCA PROGRAMME MANDATE - PROGRAMME STRUCTURE STAKEHOLDERS, STRUCTURE & COMMUNICATIONS DRAFT Terms of Reference
1. A number of national bodies are responsible for ensuring the Mental Capacity Act and Deprivation of Liberty Safeguards [Act and DoLS] are embedded in the work of the health and care sectors. Implementing
More informationTendering for Medicines and Services with CMU. Kevan Wind, Medicines Procurement Specialist Pharmacist, London & East of England
Tendering for Medicines and Services with CMU Kevan Wind, Medicines Procurement Specialist Pharmacist, London & East of England What we will cover 1. Pricing and Procurement of Medicines in the NHS. 2.
More informationTerms of Reference. 1. Oldham LSCB Vision. 2. Overall Aims. 3. Core Objectives. 4. Definitions
Terms of Reference 1. Oldham LSCB Vision Everyone to work together to ensure that all children and young people are safe and feel safe within their homes, schools and communities. 2. Overall Aims 2.1 To
More informationEffective Prescribing Programme - optimising the safe and effective use of biological medicines Case studies
Effective Prescribing Programme - optimising the safe and effective use of biological medicines Case studies Introduction These case studies outline the experiences, challenges and lessons learned to date
More informationHow Logistics Enables the Healthcare Revolution. Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company
How Logistics Enables the Healthcare Revolution Richard Holmes Managing Director of Polar Speed Distribution Ltd, a UPS company Introduction There is a revolution taking place in healthcare delivery. Patient-centred
More informationSOUTH WARWICKSHIRE NHS FOUNDATION TRUST
at 9.00am in the Brooke Suite, Warwick Hospital Present: Rosemary Hyde (RH) Non-Executive Director (NED) and Committee Chair Bruce Paxton (BP) NED Simon Page (SP) NED In attendance: Glen Burley (GB) Chief
More informationRoyal National Orthopaedic Hospital Trust (RNOH)
Royal National Orthopaedic Hospital Trust (RNOH) BGM Submission Document [Insert date of BGM submission] [Insert planned date to enter DH process as per TFA] 43 Contents Page Board context 45 Summary results
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Public Board Meeting held on the 16 March 2016 at Morriston Hospital, Heol Maes Eglwys, Morriston, Swansea, SA6 7TU These notes are a summary record of
More informationNHS Central London CCG QIPP Development 2014/15
NHS Central London CCG QIPP Development 2014/15 Contents Section 1: Context Section 2: Our Commitment System Wide Change Section 3: Key Activities Section 4: Benchmarking Tools Examples of Benchmarking
More informationMedicines optimisation & the model hospital
Medicines optimisation & the model hospital - Securing value from medicines Andrew Davies, Professional Lead for Hospital Pharmacy, NHS Improvement Andrew.davies@nhs.net @HospChiefPharm Commissioning Chemotherapy
More informationRISK MANAGEMENT COMMITTEE TERMS OF REFERENCE
RISK MANAGEMENT COMMITTEE TERMS OF REFERENCE Terms of Reference Agreed by the Committee Signed by the Chair on Behalf of the Committee Print Signature Date 16 th December 2011 Review Date December 2012
More informationConsultation on proposals for a new Cancer Drugs Fund (CDF) operating model: Q&A
Consultation on proposals for a new Cancer Drugs Fund (CDF) operating model: Q&A NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.
More informationAppendix 1 GPFV Plan Stage 2 Review CCG(s) Cambridgeshire and Peterborough CCG Rating Comments/recommendations Green Green Green Green Amber/green
Appendix 1 GPFV Plan Stage 2 Review CCG(s) Cambridgeshire and Peterborough CCG Rating Comments/recommendations Model of care Green The plan illustrates clearly how the different models of care will be
More informationBoard Assurance and Escalation Framework
Lincolnshire Partnership NHS Foundation Trust (LPFT) Board Assurance and Escalation Framework DOCUMENT VERSION CONTROL Document Type and Title: Policy No 5a. with effect from 2/11/15 (former corporate
More informationSOMERSET PARTNERSHIP NHS FOUNDATION TRUST BUSINESS ACTION PLAN 2017/18. Report to the Trust Board 23 May 2017
SOMERSET PARTNERSHIP NHS FOUNDATION TRUST BUSINESS ACTION PLAN /18 Report to the Trust Board 23 May Sponsoring Director: Author: Purpose of the report: Key Issues and Recommendations: Director of Finance
More informationInvitation To Quote. Evaluation Services Date of issue August eahsn.org
Invitation To Quote Evaluation Services Date of issue August 2018 eahsn.org @TheEAHSN About the Eastern Academic Health Science Network Galvanising people to advance health and wealth Eastern Academic
More informationAgenda Item 8. Page 31
Agenda Item 8 Proposed Governance Arrangements for Joint Commissioning of Health and Social Care between Lincolnshire County Council, the Four Lincolnshire Clinical Commissioning Groups and the Local Area
More informationAttendance: Dianne Willcocks, Chairperson Libby Raper Sue Symington Mike Proctor Polly McMeekin Tracy Astley (minutes)
Workforce & Organisational Development Committee 20 th July 2016 Meeting Room 1, Park House, York Hospital Attendance: Dianne Willcocks, Chairperson Libby Raper Sue Symington Mike Proctor Polly McMeekin
More informationLearning and development policy. Document author Assured by Review cycle. 1. Introduction Policy statement Purpose or aim...
Learning and development policy Board library reference Document author Assured by Review cycle P090 Head of Learning and Development Quality and Standards Committee 3 years This document is version controlled.
More informationACE 2016 EPR Downtime Sarah Hulme, Head of EPR Development Andrea Popplewell, Head of Technical Development Salford Royal Foundation Trust, UK
AUGUST 9 11, 2016 ACE 2016 EPR Downtime Sarah Hulme, Head of EPR Development Andrea Popplewell, Head of Technical Development Salford Royal Foundation Trust, UK AUGUST 9, 2016 WELCOME! Salford Royal NHS
More informationCommunity Health Partnerships: Progress Report and Model Scheme of Establishment
EMBARGOED UNTIL MEETING Greater Glasgow NHS Board Board Meeting Tuesday 21 st December 2004 Board Paper No. 2004/64 Director of Planning and Community Care Community Health Partnerships: Progress Report
More informationTHE ROYAL MARSDEN WELCOME AND ONBOARDING POLICY AND PROCEDURE
THE ROYAL MARSDEN WELCOME AND ONBOARDING POLICY AND PROCEDURE Summary The Royal Marsden is committed to providing a supportive and robust onboarding programme to enable all new staff to settle into their
More informationThe initial business case suggested a number of benefits which could be derived from the pilot which have been evaluated below:
PROCUREMENT of ARDENS TEMPLATE SYSTEM 1. Executive Summary A business case was submitted to Norwich CCG in January 2017 requesting approval to run a pilot of the Ardens Clinical Templates which sit within
More informationAudit Committee Annual Report. Director of Corporate Governance. Stage 1 only (no negative impacts identified)
Paper 6 Recommendation The Trust Board is asked to NOTE the Audit Committee Annual Report DECISION NOTE Reporting to: Trust Board Date 25 May 2018 Paper Title Brief Description Audit Committee Annual Report
More informationTitle of Meeting: Governing Body Agenda Item: 7.4
Title of Meeting: Governing Body Agenda Item: 7.4 Date of Meeting: 6 April 2017 Paper Title: HaRD CCG Draft Governing Body Assurance Framework Refresh Responsible Governing Body Member Lead Joanne Crewe,
More informationUse of Resources: assessment framework
Use of Resources: assessment framework August 2017 Delivering better healthcare by inspiring and supporting everyone we work with, and challenging ourselves and others to help improve outcomes for all.
More informationRemuneration Consultants Group
Remuneration Consultants Group The Board s activities in 2014 and the review of the effectiveness of the Code September 2014 Page 1 of 15 Contents A. The RCG and its activities in 2014... 3 B. The Review
More informationNHS England, National QIPP Delivery Programme, Medicines Management & Optimisation
NHS England, National QIPP Delivery Programme, Medicines Management & Optimisation Biosimilars National Surveys; CCGs and NHS Trusts Summary Report - April 2018 1.0 Background This report summarises the
More informationBelfast Heath and Social Care Trust (BHSCT) Personal and Public Involvement (PPI) Monitoring Report May 2016
Belfast Heath and Social Care Trust (BHSCT) Personal and Public Involvement (PPI) Monitoring Report May 2016 Prepared by Martin Quinn and Claire Fordyce, PHA Contents Introduction... 2 Rationale for PPI...
More informationTHE IPSWICH HOSPITAL NHS TRUST. Divisional Board. TERMS OF REFERENCE Version 1.0
THE IPSWICH HOSPITAL NHS TRUST Divisional Board TERMS OF REFERENCE Version 1.0 Purpose: For use by: This document is compliant with /supports compliance with: This document supersedes: Approved by: To
More informationGREAT WESTERN HOSPITALS NHS FOUNDATION TRUST. Formulary Working Group 2.00pm 16 th July 2015 Seminar Room 5, The Academy, GWH
Formulary Working Group 2.00pm 16 th July 2015 Seminar Room 5, The Academy, GWH The 3T s Formulary Swindon CCG & Wiltshire CCG Great Western Hospitals NHS Foundation Trust (In collaboration with Avon and
More informationSpecialty Pharmacy 101
Specialty Pharmacy 101 The Landscape of Specialty Pharmacy Services DATE: October 27, 2011 NAME: TITLE: Clinical Pharmacist, Serve You Agenda Define specialty pharmacy Examine market trends and current
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 8. Date of Meeting:.27 th April 2018
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 8 Date of Meeting:.27 th April 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationFAQs about the Elections
FAQs about the Elections Being an LMC Member What is a Local Medical Committee? A Local Medical Committee (LMC) is the representative professional organisation elected by GPs to represent all NHS GPs and
More informationNHS DORSET CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING ORGANISATIONAL DEVELOPMENT FRAMEWORK UPDATE 2018/2019
NHS DORSET CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING ORGANISATIONAL DEVELOPMENT FRAMEWORK UPDATE 2018/2019 Date of the meeting 14/11/2018 Author Sponsoring Board member Purpose of Report Recommendation
More informationESNEFT Strategic Working Group engagement plan June to December 2018
ESNEFT Strategic Working Group engagement plan June to December 2018 July 2018 Objective Effective engagement by trust leadership, supported by the communication and engagement team, with staff and public
More informationInternal Business Case Template & Guidance
Internal Business Case Template & Guidance Creation of Chief Pharmacist Information Officer role at UHBristol 1. INTRODUCTION AND SUMMARY This document defines the need, strategic context and preferred
More information